Cargando…
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
Pancreatic cancer (PC) is an almost uniformly lethal disease with inflammation playing an important role in its progression. Sustained stimulation of purinergic receptor P2X7 drives induction of NLRP inflammasome activation. To understand the role of P2X7 receptor and inflammasome, we performed tran...
Autores principales: | Mohammed, Altaf, Janakiram, Naveena B., Madka, Venkateshwar, Pathuri, Gopal, Li, Qian, Ritchie, Rebekah, Biddick, Laura, Kutche, Hannah, Zhang, Yuting, Singh, Anil, Gali, Hariprasad, Lightfoot, Stan, Steele, Vernon E., Suen, Chen S., Rao, Chinthalapally V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716694/ https://www.ncbi.nlm.nih.gov/pubmed/29228654 http://dx.doi.org/10.18632/oncotarget.22085 |
Ejemplares similares
-
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023) -
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2015) -
Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016) -
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
por: Yarla, Nagendra S., et al.
Publicado: (2020) -
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice
por: Benbrook, Doris M., et al.
Publicado: (2017)